Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 39 citing articles:

2023 ESC Guidelines for the management of cardiomyopathies
Elena Arbelo, Alexandros Protonotarios, Juan R. Gimeno, et al.
European Heart Journal (2023) Vol. 44, Iss. 37, pp. 3503-3626
Open Access | Times Cited: 1038
2024 update in heart failure
Alberto Beghini, Antonio Maria Sammartino, Z. Papp, et al.
ESC Heart Failure (2024)
Open Access | Times Cited: 31
From gene-discovery to gene-tailored clinical management: 25 years of research in channelopathies and cardiomyopathies
Lia Crotti, Pedro Brugada, Hugh Calkins, et al.
EP Europace (2023) Vol. 25, Iss. 8
Open Access | Times Cited: 23
Novel Therapies for the Treatment of Cardiac Fibrosis Following Myocardial Infarction
Kamila Raziyeva, Yevgeniy Kim, Zharylkasyn Zharkinbekov, et al.
Biomedicines (2022) Vol. 10, Iss. 9, pp. 2178-2178
Open Access | Times Cited: 34
Mechanism based therapies enable personalised treatment of hypertrophic cardiomyopathy
Francesca Margara, Yiangos Psaras, Zhinuo Jenny Wang, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 20
Advances in genetic diagnosis and therapy of hereditary heart disease: a bibliometric review from 2004 to 2024
Hernández Ma, Yun Wang, Yang Jia, et al.
Frontiers in Medicine (2025) Vol. 11
Open Access
The ESC Working Group on Myocardial Function
Mahmoud Abdellatif, Wolfgang A. Linke, Dana Dawson, et al.
European Heart Journal (2025)
Closed Access
The Future of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)-Cas9 Gene Therapy in Cardiomyopathies: A Review of Its Therapeutic Potential and Emerging Applications
Ali Moradi, Sina Khoshniyat, Tochukwu Nzeako, et al.
Cureus (2025)
Open Access
Exploring the Role of ALPK3 Variants in Hypertrophic and Dilated Cardiomyopathies
Fernanda Almeida Andrade, Bruno de Oliveira Stephan, Silas Ramos Furquim, et al.
ABC Heart Failure & Cardiomyopathy (2025) Vol. 5, Iss. 1
Closed Access
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies
Marija Polovina, Carsten Tschöpe, Giuseppe Rosano, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 12, pp. 2144-2163
Closed Access | Times Cited: 7
Mechanisms of myocardial reverse remodelling and its clinical significance: A scientific statement of the ESC Working Group on Myocardial Function
Inês Falcão‐Pires, Ana Filipa Ferreira, Fábio Trindade, et al.
European Journal of Heart Failure (2024) Vol. 26, Iss. 7, pp. 1454-1479
Open Access | Times Cited: 2
Risk Assessment and Personalized Treatment Options in Inherited Dilated Cardiomyopathies: A Narrative Review
Diana-Aurora Arnăutu, Dragoș Cozma, Ioan-Radu Lala, et al.
Biomedicines (2024) Vol. 12, Iss. 8, pp. 1643-1643
Open Access | Times Cited: 2
Effectiveness of 2014 ESC HCM-Risk-SCD score in prediction of appropriate implantable-cardioverter-defibrillator shocks
Antonia Luisa Buongiorno, Alessandro Blandino, Francesca Bianchi, et al.
Journal of Cardiovascular Medicine (2023)
Closed Access | Times Cited: 6
State‐of‐the‐art document on optimal contemporary management of cardiomyopathies
Petar Seferović, Marija Polovina, Giuseppe Rosano, et al.
European Journal of Heart Failure (2023) Vol. 25, Iss. 11, pp. 1899-1922
Open Access | Times Cited: 6
Biotechnological advances and applications of human pluripotent stem cell-derived heart models
Priyadharshni Muniyandi, Colin O’Hern, Mirel Adrian Popa, et al.
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 4
The Role of Genetics in the Management of Heart Failure Patients
Gianpaolo Palmieri, Maria Francesca D’Ambrosio, Michele Correale, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15221-15221
Open Access | Times Cited: 4
Advances in Multi-Modality Imaging in Hypertrophic Cardiomyopathy
Fraser C. Goldie, Matthew M.Y. Lee, Caroline Coats, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 842-842
Open Access | Times Cited: 1
PARP9 affects myocardial function through TGF-β/Smad axis and pirfenidone
Nannan Chen, Lianzhi Zhang, Zhong Zhang, et al.
Biomolecules and Biomedicine (2024) Vol. 24, Iss. 5, pp. 1199-1215
Open Access | Times Cited: 1
Transcriptomics data integration and analysis to uncover hallmark genes in hypertrophic cardiomyopathy
Peng Chen
American Journal of Translational Research (2024) Vol. 16, Iss. 2, pp. 637-653
Open Access | Times Cited: 1
Genetics and Molecular Mechanisms of Idiopathic Dilated Cardiomyopathy, a Possible Guide to Individualized Management
Diana-Aurora Arnăutu, Octavian-Marius Cretu, Daniel Lighezan, et al.
(2024)
Open Access | Times Cited: 1
Epigenetic Study of Cohort of Monozygotic Twins With Hypertrophic Cardiomyopathy Due to MYBPC3 (Cardiac Myosin‐Binding Protein C)
Alfonso Peñarroya, Rebeca Lorca, J.J.R. Reguero, et al.
Journal of the American Heart Association (2024)
Closed Access | Times Cited: 1
Cardiologia Teoria e Prática - Edição XVIII
Guilherme Barroso Langoni de Freitas, MARCELO DANTAS CAMPOS, Beatriz Vasconcelos Cipola, et al.
(2024)
Closed Access | Times Cited: 1
AKT-mTOR signaling-mediated rescue of PRKAG2 R302Q mutant-induced familial hypertrophic cardiomyopathy by treatment with β-adrenergic receptor (β-AR) blocker metoprolol
Jian Zhuo, Hai-Hua Geng, Xiaohui Wu, et al.
Cardiovascular Diagnosis and Therapy (2022) Vol. 12, Iss. 3, pp. 360-369
Open Access | Times Cited: 6
Targeting lipid metabolism as a new therapeutic strategy for inherited cardiomyopathies
Karen R. Gaar-Humphreys, Alyssa van den Brink, Mark Wekking, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 3
Multimodal characterization of dilated cardiomyopathy: Geno‐ And Phenotyping of PrImary Cardiomyopathy (GrAPHIC)
Laura Keil, Filip Berisha, Stella Ritter, et al.
ESC Heart Failure (2023) Vol. 11, Iss. 1, pp. 541-549
Open Access | Times Cited: 3
Page 1 - Next Page

Scroll to top